Role of a novel neurppeptide, orexin,in the central regulation of gastric acid secretion

新型神经肽食欲素在胃酸分泌中枢调节中的作用

基本信息

  • 批准号:
    11670471
  • 负责人:
  • 金额:
    $ 1.15万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

We examined first the effect of intracisternal injection of orexin-A on gastric acid secretion in rats. Intracisternal injection of orexin-A dose-dependently stimulated gastric acid output by the pylorus-ligation method. In contrast, intraperitoneal administration of orexin-A failed to stimulate acid, secretion, suggesting that orexin-A acts in the brain to stimulate gastric acid secretion. The stimulation of gastric secretion was not observed in the vagotomyzed rats, indicating that the vagus nerve mediates the orexin-induced acid secretion Orexin-A is a neuropeptide consisting 33 amino acids with two intrachain disulfide bonds, namely Cys6-Cys12 and Cys7-Cys14. In contrast, orexin-B, a peptide containing 28 amino acids without disulfide bond, which has no stimulatory action of gastric acid. Intracisternal injection of orexin-A but not orexin-B or orexin-A (15-33) that does not contain both disulfide bonds stimulated gastric acid secretion in pylonis-ligated conscious rats. The abilit … More y of the stimulation of gastric acid output was less in three alanine-substituted orexin-A, [Ala 6, 12]orexin-A, [Ala 7, 14]orexin-A and [Ala 6, 7, 12, 14]orexin-A, than orexin-A, Orexins-induced calcium increase was measured in CHO-K1 cells expressing OX1R or OX2R. Orexin-A induced a transient increase in [Ca2+]i in CHO-K1/OX1R cells in a dose-dependent manner. EC50 values for OX1R of orexin-A, orexhi-B or orexin-A (15-33) was 0.068, 0.69 or 4.1 nM, respectively, suggesting that peptides containing no disulfide bonds have lower potency for the receptor. Agonistic activity for OX1R of the three orexin-A analogues with modification of one or both disulfide bonds was significantly reduced as compared with that of orexin-A. EC50 values for OX2R of orexin-A and orexin-B was almost equal but potency for the receptor of orexin-A (15-33) and three alanine substituted orexin-A was less than that of orexin-A. A significant inverse relationship between gastric acid output and EC50 values for OX1R but not OX2R was observed. These results suggested that the orexin-A-induced acid stimulation requires OX1R activation and that disulfide bonds in orexin-A may have a key role in the receptor activation. Less
我们首先检查了脑池内注射食欲素-A对大鼠胃酸分泌的影响。通过幽门结扎法,脑池内注射食欲素A剂量依赖性地刺激胃酸分泌。相反,腹膜内施用食欲素-A不能刺激胃酸分泌,表明食欲素-A在脑中起作用以刺激胃酸分泌。在迷走神经切断大鼠中未观察到胃分泌的刺激,表明迷走神经介导食欲素诱导的酸分泌食欲素-A是由33个氨基酸组成的神经肽,具有两个链内二硫键,即Cys6-Cys12和Cys7-Cys14。而食欲素B是一种由28个氨基酸组成的肽,不含二硫键,对胃酸无刺激作用。在幽门结扎的清醒大鼠中,脑池内注射食欲素-A而不是食欲素-B或不含两个二硫键的食欲素-A(15 - 33)刺激胃酸分泌。能力 ...更多信息 [Ala 6,12] orexin-A、[Ala 7,14] orexin-A和[Ala 6,7,12,14] orexin-A对胃酸分泌的刺激作用均小于orexin-A。Orexin-A以剂量依赖性方式诱导CHO-K1/OX1R细胞内[Ca2 +] i瞬时升高。食欲素-A、食欲素-B或食欲素-A(15 - 33)的OX1R的EC50值分别为0.068、0.69或4.1 nM,表明不含二硫键的肽对受体的效力较低。与orexin-A相比,具有一个或两个二硫键修饰的三种orexin-A类似物对OX1R的激动活性显著降低。Orexin-A和Orexin-B对OX2R的EC 50值几乎相等,但对Orexin-A(15 - 33)和三个丙氨酸取代的Orexin-A的受体的效力小于Orexin-A。观察到胃酸排出量与OX1R而非OX2R的EC 50值之间存在显著的负相关关系。这些结果表明,食欲素-A诱导的酸刺激需要OX1R激活,食欲素-A中的二硫键可能在受体激活中起关键作用。少

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Okumura T, et al.: "Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation."Biochem Biophys Res Commun. (in press). (2001)
Okumura T 等人:“在食欲素 A 诱导的 OX1 受体激活介导的胃酸分泌刺激中需要完整的二硫键。”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Okumura T, et al.: "Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OXi receptor activation"Biochem Biophys Res Commun. 280. 976-981 (2001)
Okumura T 等人:“在 OXi 受体激活介导的食欲素 A 诱导的胃酸分泌刺激中需要完整的二硫键”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

OKUMURA Toshikatsu其他文献

Liquid biopsy of pancreatic tumors: Challenges for early detection and surveillance based on the molecular landscape during early carcinogenesis
胰腺肿瘤的液体活检:基于早期癌变过程中分子景观的早期检测和监测的挑战
  • DOI:
    10.2958/suizo.35.302
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    OKADA Tetsuhiro;MIZUKAMI Yusuke;HAYASHI Akihiro;KAWABATA Hidemasa;SATO Hiroki;KAWAMOTO Toru;GOTO Takuma;TANIUE Kenzui;ONO Yusuke;KARASAKI Hidenori;OKUMURA Toshikatsu
  • 通讯作者:
    OKUMURA Toshikatsu

OKUMURA Toshikatsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('OKUMURA Toshikatsu', 18)}}的其他基金

Anti-tumor action by PPARgamma ligands in pancreatic cancer: analysis of angigenesis-related genes expression
PPARγ配体在胰腺癌中的抗肿瘤作用:血管生成相关基因表达分析
  • 批准号:
    22590753
  • 财政年份:
    2010
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanism of the PPARγ ligand-induced growth arrest in GI cancers
PPARγ配体诱导胃肠癌生长停滞的分子机制
  • 批准号:
    18590666
  • 财政年份:
    2006
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Inhibition of cell growth and cell invasion by PPAR gamma in GI cancers
PPAR gamma 抑制胃肠道癌症中的细胞生长和细胞侵袭
  • 批准号:
    16590568
  • 财政年份:
    2004
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Aproteasome-p27 system is involved in growth inhibition by PPARγ ligands in GI cancers
Aproteasome-p27 系统参与 PPARγ 配体对胃肠道癌症的生长抑制
  • 批准号:
    14570438
  • 财政年份:
    2002
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Clinical investigation on factors affecting pharmacokinetics for the individual dosing design of orexin receptor antagonists
食欲素受体拮抗剂个体化给药设计影响药代动力学因素的临床研究
  • 批准号:
    23K06237
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of interindividual variability in pharmacokinetics of and clinical responses to orexin receptor antagonists in cancer status
癌症状态下食欲素受体拮抗剂的药代动力学和临床反应的个体差异研究
  • 批准号:
    23K06254
  • 财政年份:
    2023
  • 资助金额:
    $ 1.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Orexin Receptor Antagonists as Modulators of Threat Sensitivity in individuals with Alcohol Use Disorder
食欲素受体拮抗剂作为酒精使用障碍患者威胁敏感性的调节剂
  • 批准号:
    10704154
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Orexin Receptor Antagonists as Modulators of Threat Sensitivity in individuals with Alcohol Use Disorder
食欲素受体拮抗剂作为酒精使用障碍患者威胁敏感性的调节剂
  • 批准号:
    10590414
  • 财政年份:
    2022
  • 资助金额:
    $ 1.15万
  • 项目类别:
Treatment of Sleep Disturbances in TBI with Orexin Receptor Antagonist
食欲素受体拮抗剂治疗 TBI 睡眠障碍
  • 批准号:
    10248584
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Treatment of Sleep Disturbances in TBI with Orexin Receptor Antagonist
食欲素受体拮抗剂治疗 TBI 睡眠障碍
  • 批准号:
    10447665
  • 财政年份:
    2021
  • 资助金额:
    $ 1.15万
  • 项目类别:
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
  • 批准号:
    10417029
  • 财政年份:
    2019
  • 资助金额:
    $ 1.15万
  • 项目类别:
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
  • 批准号:
    10589068
  • 财政年份:
    2019
  • 资助金额:
    $ 1.15万
  • 项目类别:
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic Stress
Suvorexant:一种双重食欲素受体拮抗剂,用于治疗创伤后应激障碍的睡眠障碍
  • 批准号:
    9565433
  • 财政年份:
    2019
  • 资助金额:
    $ 1.15万
  • 项目类别:
Role of lateral habenula orexin receptor signaling in aggressive social behavior
外侧缰核食欲素受体信号在攻击性社会行为中的作用
  • 批准号:
    9421182
  • 财政年份:
    2017
  • 资助金额:
    $ 1.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了